U.S. market Closed. Opens in 1 day 23 hours 18 minutes

PKBO | Peak Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue367.88K607.68K528.31KN/AN/A
Cost of Revenue107.00108.00N/AN/AN/A
Gross Profit367.77K607.57K528.31KN/AN/A
Operating Expenses1.35K12.46M9.59M2.61K1.27K
Selling, General & Admin1.25K8.53M2.47M2.35K1.23K
Research & Development1.63M3.92M7.12MN/AN/A
Other Operating ExpensesN/A-819.06KN/AN/AN/A
Operating Income-1.41K-11.85M-9.07M-2.39K-1.24K
Other Expenses / Income151.00-1.31M855.02K-68.00-29.00
Before Tax Income-1.26K-13.16M-8.21M-2.46K-1.27K
Income Tax ExpensesN/A-74.00K82.07KN/AN/A
Net Income-1.26K-13.09M-8.29M-2.46K-1.27K
Interest Expenses-2.73M47.96K11.47KN/AN/A
Basic Shares Outstanding29.54M17.71M17.16M6.72M3.64M
Diluted Shares Outstanding29.54M17.71M17.16M6.72M3.64M
EBITDA-1.36K-11.88M-8.89M-2.35K-1.23K
EBITDA Margin-0.37%-1,954.70%-1,682.49%0.00%0.00%
EBIT-2.73M-13.11M-8.20M-2.46K-1.27K
EBIT Margin-741.92%-2,158.17%-1,551.94%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙